Neuroprotective role of hydroxychloroquine and trimebutine in alzheimer’s disease: Network pharmacology and molecular simulations
Alzheimer's disease (AD) is the most common neurodegenerative pathology worldwide and is marked by the progressive loss of neurons. The current therapeutic armamentarium, which is composed mostly of cholinesterase inhibitors, only provides symptomatic amelioration and is often plagued with undesirable adverse events wh...